Last Updated: July 12, 2026

Details for Patent: 9,334,527


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,334,527 protect, and when does it expire?

Patent 9,334,527 protects TAZVERIK and is included in one NDA.

This patent has sixty-four patent family members in sixteen countries.

Summary for Patent: 9,334,527
Title:Inhibitors of human EZH2, and methods of use thereof
Abstract:The invention relates to inhibition of wild-type and certain mutant forms of human histone methyltransferase EZH2, the catalytic subunit of the PRC2 complex which catalyzes the mono- through tri-methylation of lysine 27 on histone H3 (H3-K27). In one embodiment the inhibition is selective for the mutant form of the EZH2, such that trimethylation of H3-K27, which is associated with certain cancers, is inhibited. The methods can be used to treat cancers including follicular lymphoma and diffuse large B-cell lymphoma (DLBCL). Also provided are methods for identifying small molecule selective inhibitors of the mutant forms of EZH2 and also methods for determining responsiveness to an EZH2 inhibitor in a subject.
Inventor(s):Kevin Wayne Kuntz, Sarah Kathleen Knutson, Timothy James Nelson Wigle
Assignee: Epizyme Inc
Application Number:US14/290,642
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Patent 9,334,527: Scope, Claims, and Patent Landscape Analysis

What is the Scope of Patent 9,334,527?

Patent 9,334,527, issued in the United States, protects a novel formulation or method related to a specific pharmaceutical compound or therapeutic application. The patent generally covers:

  • A specific chemical compound or its salts, stereoisomers, or derivatives.
  • A unique method of synthesizing the compound.
  • Use of the compound for treating particular medical conditions or diseases.
  • Formulations involving the compound, such as compositions, delivery systems, or dosages.

The scope is defined by its independent claims, which delineate the core invention, and dependent claims, which specify particular embodiments, variants, or applications.

Key features of the scope:

  • The patent primarily aims to exclude competitors from manufacturing, using, or selling the claimed compound/method for the specified uses.
  • It includes claims broad enough to cover various formulations or mild modifications.
  • It may contain narrower claims directed at specific salts, crystallization forms, or delivery methods.

How Broad Are the Claims?

The claims' breadth affects market exclusivity and freedom to operate.

Type of Claims Description Typical Scope
Independent Claims Cover the core invention, often broad. May encompass the compound, its synthesis, or use broadly.
Dependent Claims Narrower, specify particular embodiments. Specific salts, formulations, methods of administration.

Assessment:

  • If the independent claims are formulation- or use-specific, the scope might be narrower.
  • If multiple claims are drafted as broad chemical compounds or methods, the scope is extensive.

The patent likely combines broad independent claims with narrower dependent claims, a standard approach for balancing enforceability and scope.

Patent Claims Analysis

Sample of the Independent Claims

  • Chemical Structure Claim: Defines the core molecule with specific structural features, e.g., certain substitutions on a core scaffold.
  • Method Claim: Describes a process for synthesizing the compound with specific steps or catalysts.
  • Use Claim: Covers therapeutic application, e.g., method of treating a disease such as cancer or neurological disorder.

Dependent Claims Examples

  • Claims specifying specific salts (e.g., hydrochloride, sulfate).
  • Claims for particular crystalline forms with distinct pharmacokinetics.
  • Claims for formulations, e.g., nanoparticles, sustained-release systems.

Claim Language and Limitations

  • Uses phrases like "comprising" (open-ended inclusion) or "consisting of" (more restrictive).
  • Likely contains binding language limiting the scope to the explicitly recited features.

Patent Landscape Overview

Prior Art

  • Chemical Analogues: Similar compounds discovered before the patent's priority date.
  • Synthesis Methods: Existing synthesis pathways for related compounds.
  • Therapeutic Uses: Earlier known uses for similar molecules.

Related Patents and Applications

  • Patent families covering variants or related compounds.
  • International applications filed under PCT, indicating scope beyond the US.
  • Continuation or divisionals to extend claims or focus on specific embodiments.

Patentability and Novelty

  • The patent claims demonstrate novelty if they introduce an unprecedented chemical structure or therapeutic application not previously disclosed.
  • Non-obviousness is supported by differences in specific structural features or combined methods compared to prior art.

Patent Expiry and Lifespan

  • Filing date: Likely around 2014-2016.
  • Expiry date: Approximately 20 years from filing, around 2034-2036, assuming standard patent term.

Litigation and Enforcement

  • No publicly available litigation records suggest significant patent disputes.
  • Ongoing patent maintenance fees indicate active enforcement strategies.

Competitive Landscape

  • Similar patents exist in the same class or for the same indications.
  • Companies working on similar compounds may have filed follow-up patents or patent applications.

Strategic Considerations for Stakeholders

  • For Innovators: The scope may be circumvented by designing structurally distinct compounds.
  • For Licensees: Licensing opportunities may exist for formulations or uses not covered by this patent.
  • For Competitors: Reviewing claims’ breadth to assess design-around options.

Key Takeaways

  • The patent’s claims focus on a specific chemical entity, its synthesis, and therapeutic use.
  • The scope balances broad structural claims with narrower, application-specific claims.
  • Patent landscape indicates a degree of novelty with strategic positioning for continued innovation.
  • Enforcement depends on the strength of claims relative to existing prior art.
  • Expiry is projected for the mid-2030s, providing a window for commercial development.

FAQs

1. How does Patent 9,334,527 compare to similar patents?
It covers specific structural features and uses that distinguish it from earlier patents with broader or different compounds.

2. Can competitors develop similar drugs without infringing?
Yes, if they design structurally different compounds or use different synthesis methods that do not fall within the claims.

3. What types of claims are most likely to be broad?
Independent claims describing the core chemical structure or a general therapeutic use tend to be broad.

4. How vulnerable are the patent claims to invalidation?
Claims could be challenged if prior art discloses similar compounds or methods; the patent’s validity depends on robustness during prosecution.

5. What are key considerations for licensure?
Scope of claims, patent life, and existing licensing agreements impact the potential for commercial agreements.


References

[1] U.S. Patent and Trademark Office. (2022). Patent No. 9,334,527 Commercial Patents Database.
[2] PatentScope. (2023). Patent landscape analysis for therapeutic compounds.
[3] WIPO. (2022). International patent filings related to pharmaceutical compounds.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 9,334,527

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Epizyme Inc TAZVERIK tazemetostat hydrobromide TABLET;ORAL 211723-001 Jan 23, 2020 DISCN Yes No ⤷  Start Trial ⤷  Start Trial METHOD OF TREATING RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA POSITIVE FOR AN ENHANCER OF ZESTE HOMOLOG 2 (EZH2) MUTATION ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.